Sarepta Therapeutics Inc (SRPT) — Cash Flow Reinvestment Rate
Sarepta Therapeutics Inc (SRPT) has a Cash Flow Reinvestment Rate of 1.16x as of December 2025, reinvesting $151.71 Million (capex $5.83 Million plus investments $-145.88 Million) from operating cash flow of $131.21 Million. Explore Sarepta Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sarepta Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Sarepta Therapeutics Inc across 1 annual periods. Also explore total assets of Sarepta Therapeutics Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sarepta Therapeutics Inc (2020–2020)
Year-by-year capital reinvestment analysis for Sarepta Therapeutics Inc. For live market cap and broader valuation context, see SRPT company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 2.11x | $226.29 Million | $107.47 Million | $82.20 Million | — |